Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. 1999

P Ribaud, and C Chastang, and J P Latgé, and L Baffroy-Lafitte, and N Parquet, and A Devergie, and H Espérou, and F Sélimi, and V Rocha, and H Espérou, and F Sélimi, and V Rocha, and F Derouin, and G Socié, and E Gluckman
Département de Biostatistique et Informatique Médicale, Hôpital Saint-Louis, Paris, France. patricia.ribaud@chu-stlouis.fr

To determine prognostic factors for survival in bone marrow transplant recipients with invasive aspergillosis (IA), we retrospectively reviewed 27 IA cases observed in our bone marrow transplantation unit between January 1994 and October 1994. On 30 September 1997, six patients were alive and disease-free. The median survival after IA diagnosis was 36 days. Of eight variables found to be related to survival according to the univariate analysis, graft-versus-host disease (GVHD) status at IA diagnosis (P = .0008) and the cumulative prednisolone dose taken during the week preceding IA diagnosis (CPDlw) (P < .0001) were selected by a backward stepwise Cox regression model. A three-stage classification was established: CPD1w of < or =7 mg/kg (3 of 8 patients died; 60-day survival rate, 88%), CPD1w of >7 mg/kg and no GVHD (9 of 10 patients died; 60-day survival rate, 20%), and CPD1w of >7 mg/kg and active acute grade 2 or more or extensive chronic GVHD (9 of 9 patients died; 30-day survival rate, 0) (P < .0001).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001228 Aspergillosis Infections with fungi of the genus ASPERGILLUS. Aspergillus Infection,Aspergilloses,Aspergillus Infections,Infection, Aspergillus,Infections, Aspergillus
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

P Ribaud, and C Chastang, and J P Latgé, and L Baffroy-Lafitte, and N Parquet, and A Devergie, and H Espérou, and F Sélimi, and V Rocha, and H Espérou, and F Sélimi, and V Rocha, and F Derouin, and G Socié, and E Gluckman
May 1989, The American journal of the medical sciences,
P Ribaud, and C Chastang, and J P Latgé, and L Baffroy-Lafitte, and N Parquet, and A Devergie, and H Espérou, and F Sélimi, and V Rocha, and H Espérou, and F Sélimi, and V Rocha, and F Derouin, and G Socié, and E Gluckman
January 1994, Psychosomatic medicine,
P Ribaud, and C Chastang, and J P Latgé, and L Baffroy-Lafitte, and N Parquet, and A Devergie, and H Espérou, and F Sélimi, and V Rocha, and H Espérou, and F Sélimi, and V Rocha, and F Derouin, and G Socié, and E Gluckman
September 1988, Bone marrow transplantation,
P Ribaud, and C Chastang, and J P Latgé, and L Baffroy-Lafitte, and N Parquet, and A Devergie, and H Espérou, and F Sélimi, and V Rocha, and H Espérou, and F Sélimi, and V Rocha, and F Derouin, and G Socié, and E Gluckman
June 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
P Ribaud, and C Chastang, and J P Latgé, and L Baffroy-Lafitte, and N Parquet, and A Devergie, and H Espérou, and F Sélimi, and V Rocha, and H Espérou, and F Sélimi, and V Rocha, and F Derouin, and G Socié, and E Gluckman
January 2002, Haematologia,
P Ribaud, and C Chastang, and J P Latgé, and L Baffroy-Lafitte, and N Parquet, and A Devergie, and H Espérou, and F Sélimi, and V Rocha, and H Espérou, and F Sélimi, and V Rocha, and F Derouin, and G Socié, and E Gluckman
June 2000, The Journal of thoracic and cardiovascular surgery,
P Ribaud, and C Chastang, and J P Latgé, and L Baffroy-Lafitte, and N Parquet, and A Devergie, and H Espérou, and F Sélimi, and V Rocha, and H Espérou, and F Sélimi, and V Rocha, and F Derouin, and G Socié, and E Gluckman
October 1999, European journal of pediatrics,
P Ribaud, and C Chastang, and J P Latgé, and L Baffroy-Lafitte, and N Parquet, and A Devergie, and H Espérou, and F Sélimi, and V Rocha, and H Espérou, and F Sélimi, and V Rocha, and F Derouin, and G Socié, and E Gluckman
March 2000, Clinics in laboratory medicine,
P Ribaud, and C Chastang, and J P Latgé, and L Baffroy-Lafitte, and N Parquet, and A Devergie, and H Espérou, and F Sélimi, and V Rocha, and H Espérou, and F Sélimi, and V Rocha, and F Derouin, and G Socié, and E Gluckman
February 2008, Clinical orthopaedics and related research,
P Ribaud, and C Chastang, and J P Latgé, and L Baffroy-Lafitte, and N Parquet, and A Devergie, and H Espérou, and F Sélimi, and V Rocha, and H Espérou, and F Sélimi, and V Rocha, and F Derouin, and G Socié, and E Gluckman
November 1990, Archives of dermatology,
Copied contents to your clipboard!